DrugPatentWatch Database Preview
Cadila Pharms Ltd Company Profile
What is the competitive landscape for CADILA PHARMS LTD, and what generic and branded alternatives to CADILA PHARMS LTD drugs are available?
CADILA PHARMS LTD has twenty approved drugs.
There is one tentative approval on CADILA PHARMS LTD drugs.
Summary for Cadila Pharms Ltd
| US Patents: | 0 |
| Tradenames: | 18 |
| Ingredients: | 18 |
| NDAs: | 20 |
Drugs and US Patents for Cadila Pharms Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cadila Pharms Ltd | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 206173-001 | May 5, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | CELECOXIB | celecoxib | CAPSULE;ORAL | 208701-004 | Nov 14, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | TELMISARTAN | telmisartan | TABLET;ORAL | 208605-002 | Jul 25, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | GLYBURIDE | glyburide | TABLET;ORAL | 203379-003 | Jan 4, 2019 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 206250-002 | Nov 21, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
